Gene expression of residual breast cancer after primary chemotherapy based on doxorubicin (2007)
Source: Clinics. Conference titles: Simpósio avanços em pesquisas médicas. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS (INFLUÊNCIAS), EXPRESSÃO GÊNICA, MEDICAMENTO (EFEITOS ADVERSOS), RESUMOS (SIMPÓSIOS)
ABNT
BARROS, M. C. F. et al. Gene expression of residual breast cancer after primary chemotherapy based on doxorubicin. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 13 out. 2024. , 2007APA
Barros, M. C. F., Folgueira, M. A. A. K., Katayama, M. L. H., Brentani, H., Carraro, D. M., Netto, M. M., et al. (2007). Gene expression of residual breast cancer after primary chemotherapy based on doxorubicin. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.NLM
Barros MCF, Folgueira MAAK, Katayama MLH, Brentani H, Carraro DM, Netto MM, Barbosa EM, Brentani MM. Gene expression of residual breast cancer after primary chemotherapy based on doxorubicin. Clinics. 2007 ; 62 S50.[citado 2024 out. 13 ]Vancouver
Barros MCF, Folgueira MAAK, Katayama MLH, Brentani H, Carraro DM, Netto MM, Barbosa EM, Brentani MM. Gene expression of residual breast cancer after primary chemotherapy based on doxorubicin. Clinics. 2007 ; 62 S50.[citado 2024 out. 13 ]